Hybrid coronary revascularization in multivessel coronary artery disease: a systematic review

Antonio Nenna1, Francesco Nappi2, Cristiano Spadaccio3

  • 1Cardiovascular Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, Rome, 00128, Italy.

Future Cardiology
|January 10, 2022
PubMed

Insights

Hybrid coronary revascularization (HCR) offers benefits for multivessel coronary artery disease (CAD) in select patients. However, conventional coronary artery bypass grafting (CABG) remains superior for high-risk individuals with complex disease.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Multivessel coronary artery disease (CAD) requires effective revascularization strategies.
  • Hybrid coronary revascularization (HCR) combines surgical (CABG) and percutaneous (PCI) approaches.
  • The optimal role of HCR in CAD management is under investigation.

Purpose of the Study:

  • To systematically review the current evidence on hybrid coronary revascularization (HCR).
  • To summarize the state-of-the-art of HCR for multivessel coronary artery disease (CAD).

Main Methods:

  • Systematic literature search of major databases up to October 2021.
  • Inclusion of randomized trials, meta-analyses, and retrospective studies.
  • Synthesis of available data on HCR outcomes.

Main Results:

  • Evidence includes 3 randomized trials, 10 meta-analyses, and 27 retrospective studies.
  • HCR shows greatest benefit in low-to-intermediate risk patients with less complex coronary anatomy.
  • Conventional CABG is favored for highly complex disease and high-risk patients regarding adverse events and survival.

Conclusions:

  • HCR is a viable approach for specific multivessel CAD patient subsets.
  • HCR is not a universal solution and patient selection is crucial.
  • Further research is needed to define optimal patient candidates for HCR.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...